 |
인쇄하기
취소
|
Drug price negotiation for lung cancer treatment ‘Tagrisso’ failed
The drug price negotiation of ‘Tagrisso,’ a new lung cancer drug of AstraZeneca, a multinational pharmaceutical company, was delayed for a week due to the Ministry of Health and Welfare’s order to suspend negotiation, which has attracted attention of the industry.
According to the pharmaceutical industry on the 16th, the drug price negotiation with the National Health Insurance Service did not...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.